What are the guidelines for thrombolytic treatment in acute myocardial infarction?

The benefit of early thrombolytic treatment (before 12 hours of symptom onset) is well studied and has shown a reduction of 18% in mortality.
Trombolytics increase the risk of bleeding, including hemorrhagic stroke, by 1%.
Thrombolysis should only be performed in patients with STEMI who cannot be transferred for primary PCI within 120 minutes.
The preferred agents are fibrin-specific agents (tPA, reteplase, anistreplase, tenecteplase) over non-fibrin-specific agents (streptokinase).
Thrombolysis should never be applied in patients with NSTEMI or unstable angina.
a) I, II, III, IV, and V are correct.
b) I, II, III, and IV are correct.
c) II, III, IV, and V are correct.
d) I, III, IV, and V are correct.